TimothyYash922 TimothyYash922 22-01-2024 Medicine contestada Monitoring every 6 months after initiating IL-6 inhibitors (Sarilumab and Tocilizumab) may include:a) Liver function tests (LFTs)b) Lipid profilec) Complete blood count (CBC)d) Assessment of treatment response